EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Outcomes of Endoscopic Resection for Large (>3 cm) Ampullary Tumors

Tian-Yu Zhang iD, Zhang-Han Chen, Dong-Li He, Jia Song, Lin-Da Li, Han-Xiao Zhang, Yun-Shi Zhong, Yan Wang

Endoscopy International Open · 23.09.2026 · 14 (CP)

DOI: 10.1055/a-2961-1504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 23.09.2026. Verfasst von Tian-Yu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy centerZhong Shan HospitalShanghaiShanghaiChina. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Study Aims Current guidelines recommend en bloc endoscopic resection (ER) for ampullary tumors up to 3 cm and surgery for those exceeding 4 cm, based on low-quality evidence. Robust clinical data and operative experience with ER for tumors >3 cm are relatively limited. This study aimed to investigate the safety and efficacy of ER for large ampullary tumors exceeding 3 cm. Patients and Methods This retrospective study included 28 patients with large ampullary tumors (>3 cm) treated with ER at two tertiary academic endoscopy centers from September 2017 to July 2025. Clinical, endoscopic, and pathological records and follow-up data were collected and analyzed.

Results

All 28 patients successfully underwent ER with a complete ER rate of 100% and an R0 resection rate of 67.9%. The overall postoperative delayed bleeding rate was 14.3% (4/28; 95% CI: 5.7–31.5%). In subgroup data, bleeding occurred in 2 of 24 patients (8.3%; 95% CI: 1.5–25.8%) with stent placement, in 2 of 4 patients (50.0%; 95% CI: 8.9–91.1%) without stent placement; bleeding occurred in 3 of 27 patients (11.1%; 95% CI: 3.9–28.1%) with wound closure, and in the single patient without wound closure (100%; 95% CI: 5.1–100.0%). All bleeding events were managed endoscopically. No other adverse events occurred. After a mean follow-up of 27.4 months (range 10.0–97.0 months), two patients (7.1%) developed recurrence and underwent surgical resection (n = 1) or repeat ER (n = 1).

Conclusions

ER appears safe and effective for ampullary tumors exceeding 3 cm. The potential roles of wound closure and stent placement in reducing adverse events require validation in larger comparative trials.

Schlagwörter

Stichwörter der Autor:innen

endoscopic resection (ESD, EMRc, …)endoscopy upper GI tractprecancerous conditions & cancerous lesions (dysplasia and cancer) stomach

Autor:innen und Institutionen

  • Endoscopy centerZhong Shan HospitalShanghaiShanghaiChina.
  • Endoscopy centerShanghai Xuhui Central HospitalShanghaiShanghaiChina.
  • Endoscopy centerZhongshan Hospital Fudan UniversityShanghaiShanghaiChina.
  • Department of GastroenterologyRongcheng Hospital of Traditional Chinese MedicineWeihaiShandongChina.

ORCID-Profile: Tian-Yu Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, T. Y., Chen, Z. H., He, D. L., Song, J., Li, L. D., Zhang, H. X., Zhong, Y. S., & Wang, Y. (2026). Clinical Outcomes of Endoscopic Resection for Large (>3 cm) Ampullary Tumors. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2961-1504

Vancouver

Zhang TY, Chen ZH, He DL, Song J, Li LD, Zhang HX, et al. Clinical Outcomes of Endoscopic Resection for Large (>3 cm) Ampullary Tumors. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2961-1504

BibTeX
@article{Zhang2026,
  author = {Zhang, Tian-Yu and Chen, Zhang-Han and He, Dong-Li and Song, Jia and Li, Lin-Da and Zhang, Han-Xiao and Zhong, Yun-Shi and Wang, Yan},
  title = {Clinical Outcomes of Endoscopic Resection for Large (>3 cm) Ampullary Tumors},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2961-1504}
}
Kostenlos starten →